Equities
  • Price (EUR)3.45
  • Today's Change-0.025 / -0.72%
  • Shares traded165.60k
  • 1 Year change+10.24%
  • Beta0.5950
Data delayed at least 15 minutes, as of Nov 21 2024 16:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Faes Farma SA had little change in net income (from 89.55m to 91.90m). Revenues were also little changed (from 438.75m to 451.17m.)
Gross margin66.53%
Net profit margin19.97%
Operating margin22.53%
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in EURView more

In 2023, cash reserves at Faes Farma SA fell by 31.76m. However, the company earned 100.97m from its operations for a Cash Flow Margin of 22.38%. In addition the company used 97.36m on investing activities and also paid 35.38m in financing cash flows.
Cash flow per share0.3803
Price/Cash flow per share9.35
Book value per share--
Tangible book value per share--
More ▼

Balance sheet in EURView more

Faes Farma SA uses little or no debt in its capital structure.
Current ratio--
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼

Growth rates in EUR

Year on year, growth in earnings per share excluding extraordinary items increased 4.58%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)--
Div growth rate (5 year)52.23%
Payout ratio (TTM)37.00%
EPS growth(5 years)12.75
EPS (TTM) vs
TTM 1 year ago
10.68
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.